September - 2016
| Previous Past Months | Showing Journal 6 of 6 |
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa InhibitorsStuart J. Connolly, Truman J. Milling, John W. Eikelboom, et al for the ANNEXA-4 Investigators New Eng J Med, 2016, online first 30th August |
September |
Previous Comments
No Comments yet.
Comment
Quickly and effectively reversing the new oral antithrombin inhibitors is a crucial next step in the evolution of this new treatment direction in AF, stroke, prevention of venous thromboembolism. In 2015 a
This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register